Senior insider sale
Chief Scientific Officer at RHYTHM PHARMACEUTICALS, INC. — senior position signals high conviction
$912.9K
7.76K shares
What this filing means
GARFIELD ALASTAIR plans to sell 7.76K shares of RHYTHM PHARMACEUTICALS, INC. valued at approximately $912.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001950047-26-008100
Officer· Chief Scientific Officer
Since Feb 2026
7.76K
Shares to sell
$912.9K
Approx. market value
7.76K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
7/1/2025
7.76KTotal acquired7.76K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2025 | Restricted Stock Units N/A | 7.76K | — |
| Total | 7.76K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.76K
Market value
$912.9K
8/13/2026
Total
Units
7.76K
Value
$912.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/13/2026 | 7.76K | $912.9K | NASDAQ | Planned |
| Total | 7.76K | $912.9K | ||